Business: ATAI Life Sciences N.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The Company's business model combines funding, technology, scientific, and regulatory expertise with a focus on innovative compounds, including psychedelic therapy and other drugs with differentiated safety profiles and therapeutic potential.